XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 10,987 $ 16,210
Adjustments to reconcile net income to cash provided by operating activities:    
Deferred income tax provision, net (244) 1,301
Provision for credit losses (40) 371
Depreciation and amortization 1,333 1,234
Stock-based compensation expense 3,501 4,326
Noncash lease expense 938 1,130
Loss on equity method investment 0 750
Other 404 50
(Increase) decrease in operating assets    
Trade receivables, net (3,456) 2,601
Other assets (608) 243
Increase (decrease) in operating liabilities    
Accrued payroll costs 5,982 (1,230)
Other liabilities (5,628) (7,930)
Cash provided by operating activities 13,169 19,056
Cash flows from investing activities:    
Capital expenditures (1,875) (1,872)
Payment to Acquire Life Insurance Policy, Investing Activities 529 0
Proceeds from the sale of our joint venture interest 0 5,059
Note receivable issued to our joint venture 0 (750)
Cash (used in) provided by investing activities (2,404) 2,437
Cash flows from financing activities:    
Proceeds from credit facility 107,600 174,200
Payments on credit facility (108,400) (177,500)
Repurchases of common stock (2,848) (11,126)
Cash dividends (7,128) (7,003)
Other (2) (14)
Cash used in financing activities (10,778) (21,443)
Change in cash and cash equivalents (13) 50
Cash and cash equivalents, beginning of period 119 121
Cash and cash equivalents, end of period 106 171
Supplemental Disclosure of Cash Flow Information    
Income taxes 300 5,108
Operating lease liabilities 1,297 1,303
Interest, net 614 248
Non-Cash Investing and Financing Transactions:    
ROU assets obtained from operating leases 1,152 566
Employee stock purchase plan 204 245
Unsettled repurchases of common stock 200 0
Equipment and software additions included in accounts payable and other accrued liabilities $ 181 $ 957